FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Effect of Meperidine on Equine Blood Histamine, Tryptase, an...
Frontiers in veterinary science2020; 7; 584922; doi: 10.3389/fvets.2020.584922

Effect of Meperidine on Equine Blood Histamine, Tryptase, and Immunoglobulin-E Concentrations.

Abstract: To evaluate changes in immunological parameters following subcutaneous (SC) and intramuscular (IM) administration of meperidine in horses through quantitative analysis of plasma tryptase, histamine, and IgE levels. Six adult horses were enrolled in a prospective randomized crossover design. Horses were administered one treatment per day, with a seven day washout period: (a) meperidine 1 mg/kg IM, saline 6 mL SC; (b) saline 6 mL IM, meperidine 1 mg/kg SC; (c) saline 6 mL SC, saline 6 mL IM. Blood samples were obtained for plasmatic histamine (baseline, 5, 10, 15, 30, and 60 min) via LC-MS/MS and plasmatic tryptase (baseline, 15, 30, 60, 120, and 240 min) quantification with enzyme-linked immunoabsorbent assays. Serum immunoglobulin E (IgE) concentrations prior to any meperidine treatment and 7-14 days following the first meperidine treatment were evaluated with enzyme-linked immunoabsorbent assays. Histamine and tryptase concentrations were evaluated with a mixed-effect analysis of variance. The levels of IgE at baseline (before the administration of the first dose of meperidine) were compared with the IgE values at 60 min following the second meperidine administration with the Paired test. Biopsies of localized injection site reactions from subcutaneous meperidine administration were collected from two horses. No statistically significant elevations from baseline in histamine ( = 0.595), tryptase ( = 0.836), or IgE ( = 0.844) were found in any of the horses in this study. There were no differences between treatment groups. Administration of SC meperidine caused a localized vasculitis and thrombosis with regional edema and hemorrhage. No evidence of anaphylactoid or anaphylactic type reactions occurred following IM or SC meperidine administration.
Copyright © 2020 Trenholme, Sakai, Berghaus, Hanafi, Knych, Ryan, McHale, Banovic, Quandt, Barletta and Reed.
Get Full Text
Publication Date: 2020-12-23 PubMed ID: 33426016PubMed Central: PMC7786019DOI: 10.3389/fvets.2020.584922Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research examines if the administration of meperidine, a type of medication, through subcutaneous (SC) and intramuscular (IM) routes in horses causes changes in the levels of some immune system parameters: histamine, tryptase, and IgE. The study results show that meperidine does not significantly increase these parameters, indicating it may not cause severe allergic reactions in horses. However, there was a local inflammation and blood clot development observed at the site of SC meperidine injection.

Study Design

  • The study involved six adult horses participating in a randomized crossover experiment where each horse experienced each treatment in different phases.
  • Three types of treatments were involved: meperidine given intramuscularly with saline subcutaneously; meperidine given subcutaneously with saline intramuscularly; and saline given both intramuscularly and subcutaneously.
  • The treatment was administered once a day with a seven-day washout period in between each phase.

Data Collection and Analysis

  • Blood samples were taken from the horses at various points in time depending on the parameter being measured: histamine was measured from baseline and every 5-60 minutes after treatment; tryptase was measured from baseline and after 15-240 minutes; and IgE was checked before any treatment and 7-14 days after the first meperidine treatment.
  • Various methods were used to evaluate these parameters: LC-MS/MS for histamine, enzyme-linked immunoabsorbent assays for tryptase and IgE.
  • For statistical analyses, histamine and tryptase concentrations were compared using a mixed-effect analysis of variance, while baseline IgE values and those after 60 minutes from the second meperidine administration were compared using the Paired t test.
  • Biopsies were also taken from two horses who showed localized reactions from the subcutaneous meperidine injection.

Findings

  • The results show that the administration of meperidine did not cause any significant increase in the levels of histamine, tryptase, and IgE in the horses.
  • There were no differences observed between the treatment groups in the levels of these parameters either.
  • Nevertheless, subcutaneous injection of meperidine led to localized inflammation and clot formation with accompanying swelling and bleeding in the area.

Conclusions

  • The study concludes that meperidine does not cause significant changes in the concentrations of histamine, tryptase, and IgE, suggesting it may not lead to severe allergic or anaphylactic reactions in horses.
  • However, a localized inflammation and clot formation was observed at the site of the subcutaneous meperidine injection, although it’s not clear how detrimental or significant this effect could be.

Cite This Article

APA
Trenholme HN, Sakai DM, Berghaus LJ, Hanafi AL, Knych HK, Ryan CA, McHale B, Banovic F, Quandt JE, Barletta M, Reed RA. (2020). Effect of Meperidine on Equine Blood Histamine, Tryptase, and Immunoglobulin-E Concentrations. Front Vet Sci, 7, 584922. https://doi.org/10.3389/fvets.2020.584922

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 7
Pages: 584922
PII: 584922

Researcher Affiliations

Trenholme, H Nicole
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
Sakai, Daniel M
  • Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
Berghaus, Londa J
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
Hanafi, Amanda L
  • Peterson and Smith Equine Hospital, Ocala, FL, United States.
Knych, Heather K
  • K.L. Maddy Equine Analytical Pharmacology Laboratory, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
  • Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States.
Ryan, Clare A
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
McHale, Brittany
  • Infectious Disease Laboratory, College of Veterinary Medicine, Department of Small Animal Medicine and Surgery, University of Georgia, Athens, GA, United States.
Banovic, Frane
  • Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
Quandt, Jane E
  • Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
Barletta, Michele
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.
Reed, Rachel A
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, United States.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 49 references
  1. Baldo BA, Pham NH. Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two.. Anaesth Intensive Care 2012 Mar;40(2):216-35.
    doi: 10.1177/0310057X1204000204pubmed: 22417016google scholar: lookup
  2. Harle DG, Baldo BA, Coroneos NJ, Fisher MM. Anaphylaxis following administration of papaveretum. Case report: Implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant.. Anesthesiology 1989 Oct;71(4):489-94.
    doi: 10.1097/00000542-198910000-00003pubmed: 2478047google scholar: lookup
  3. Mertes PM, Malinovsky JM, Jouffroy L, Aberer W, Terreehorst I, Brockow K, Demoly P. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice.. J Investig Allergol Clin Immunol 2011;21(6):442-53.
    pubmed: 21995177
  4. Wang H, Wang HS, Liu ZP. Agents that induce pseudo-allergic reaction.. Drug Discov Ther 2011 Oct;5(5):211-9.
    doi: 10.5582/ddt.2011.v5.5.211pubmed: 22466368google scholar: lookup
  5. Benyon RC, Robinson C, Church MK. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli.. Br J Pharmacol 1989 Jul;97(3):898-904.
    doi: 10.1111/j.1476-5381.1989.tb12030.xpmc: PMC1854553pubmed: 2474353google scholar: lookup
  6. Hermens JM, Ebertz JM, Hanifin JM, Hirshman CA. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone.. Anesthesiology 1985 Feb;62(2):124-9.
    doi: 10.1097/00000542-198502000-00005pubmed: 2578752google scholar: lookup
  7. Payne V, Kam PC. Mast cell tryptase: a review of its physiology and clinical significance.. Anaesthesia 2004 Jul;59(7):695-703.
    doi: 10.1111/j.1365-2044.2004.03757.xpubmed: 15200544google scholar: lookup
  8. Prieto-Lastra L, Iglesias-Cadarso A, Reaño-Martos MM, Pérez-Pimiento A, Rodríguez-Cabreros MI, García-Cubero A. Pharmacological stimuli in asthma/urticaria.. Allergol Immunopathol (Madr) 2006 Sep-Oct;34(5):224-7.
    doi: 10.1157/13094030pubmed: 17064652google scholar: lookup
  9. Dybendal T, Guttormsen AB, Elsayed S, Askeland B, Harboe T, Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia.. Acta Anaesthesiol Scand 2003 Nov;47(10):1211-8.
    doi: 10.1046/j.1399-6576.2003.00237.xpubmed: 14616317google scholar: lookup
  10. Guedes AG, Papich MG, Rude EP, Rider MA. Comparison of plasma histamine levels after intravenous administration of hydromorphone and morphine in dogs.. J Vet Pharmacol Ther 2007 Dec;30(6):516-22.
    doi: 10.1111/j.1365-2885.2007.00911.xpubmed: 17991219google scholar: lookup
  11. Guedes AG, Rudé EP, Rider MA. Evaluation of histamine release during constant rate infusion of morphine in dogs.. Vet Anaesth Analg 2006 Jan;33(1):28-35.
    doi: 10.1111/j.1467-2995.2005.00218.xpubmed: 16412130google scholar: lookup
  12. Akuzawa N, Takeda S, Ishiguro M. Structural modelling and mutation analysis of a nociceptin receptor and its ligand complexes.. J Biochem 2007 Jun;141(6):907-16.
    doi: 10.1093/jb/mvm100pubmed: 17456499google scholar: lookup
  13. Lansu K, Karpiak J, Liu J, Huang XP, McCorvy JD, Kroeze WK, Che T, Nagase H, Carroll FI, Jin J, Shoichet BK, Roth BL. In silico design of novel probes for the atypical opioid receptor MRGPRX2.. Nat Chem Biol 2017 May;13(5):529-536.
    doi: 10.1038/nchembio.2334pmc: PMC5391270pubmed: 28288109google scholar: lookup
  14. McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, Dong X. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.. Nature 2015 Mar 12;519(7542):237-41.
    doi: 10.1038/nature14022pmc: PMC4359082pubmed: 25517090google scholar: lookup
  15. Simons FE, Frew AJ, Ansotegui IJ, Bochner BS, Golden DB, Finkelman FD, Leung DY, Lotvall J, Marone G, Metcalfe DD, Müller U, Rosenwasser LJ, Sampson HA, Schwartz LB, van Hage M, Walls AF. Risk assessment in anaphylaxis: current and future approaches.. J Allergy Clin Immunol 2007 Jul;120(1 Suppl):S2-24.
    doi: 10.1016/j.jaci.2007.05.001pubmed: 17602945google scholar: lookup
  16. Sawyer DC, Rech RH, Adams T, Durham RA, Richter MA, Striler EL. Analgesia and behavioral responses of dogs given oxymorphone-acepromazine and meperidine-acepromazine after methoxyflurane and halothane anesthesia.. Am J Vet Res 1992 Aug;53(8):1361-8.
    pubmed: 1510312
  17. Nolan A, Waterman AE, Livingston A. The correlation of the thermal and mechanical antinociceptive activity of pethidine hydrochloride with plasma concentrations of the drug in sheep.. J Vet Pharmacol Ther 1988 Mar;11(1):94-102.
    doi: 10.1111/j.1365-2885.1988.tb00126.xpubmed: 3379669google scholar: lookup
  18. Kaartinen J, Lair S, Walsh MT, Burns P, Desmarchelier M, Pang JM, Pang DSJ. ANESTHESIA OF AQUARIUM-HOUSED WALRUS ( ODOBENUS ROSMARUS): A CASE SERIES.. J Zoo Wildl Med 2018 Jun;49(2):435-443.
    doi: 10.1638/2017-0167.1pubmed: 29900767google scholar: lookup
  19. Muir WW, Robertson JT. Visceral analgesia: effects of xylazine, butorphanol, meperidine, and pentazocine in horses.. Am J Vet Res 1985 Oct;46(10):2081-4.
    pubmed: 4062010
  20. Daniels AH, Ritterman SA, Rubin LE. Paralytic ileus in the orthopaedic patient.. J Am Acad Orthop Surg 2015 Jun;23(6):365-72.
    doi: 10.5435/JAAOS-D-14-00162pubmed: 25917235google scholar: lookup
  21. Clutton RE. Unexpected responses following intravenous pethidine injection in two horses.. Equine Vet J 1987 Jan;19(1):72-3.
    doi: 10.1111/j.2042-3306.1987.tb02587.xpubmed: 3691465google scholar: lookup
  22. Alexander F, Collett RA. Pethidine in the horse.. Res Vet Sci 1974 Jul;17(1):136-7.
    doi: 10.1016/S0034-5288(18)33723-8pubmed: 4421117google scholar: lookup
  23. Akcasu A, Yillar DO, Akkan AG, Küçkhüseyin C. The role of mast cells in the genesis of acute manifestations following the intravenous injection of meperidine in dogs.. J Basic Clin Physiol Pharmacol 2009;20(1):67-72.
    doi: 10.1515/JBCPP.2009.20.1.67pubmed: 19601396google scholar: lookup
  24. Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans.. Anesth Analg 1987 Aug;66(8):723-30.
    doi: 10.1213/00000539-198708000-00005pubmed: 2440351google scholar: lookup
  25. Foreman JH, Ruemmler R. Efficacy of intramuscular meperidine hydrochloride versus placebo in experimental foot lameness in horses.. Equine Vet J Suppl 2013 Dec;(45):48-53.
    doi: 10.1111/evj.12168pubmed: 24304404google scholar: lookup
  26. Laurichesse M, Gicquel T, Moreau C, Tribut O, Tarte K, Morel I, Bendavid C, Amé-Thomas P. Histamine quantification in human plasma using high resolution accurate mass LC-MS technology.. Clin Biochem 2016 Jan;49(1-2):111-6.
    doi: 10.1016/j.clinbiochem.2015.08.012pubmed: 26282720google scholar: lookup
  27. MyBioSource nEquine Tryptase (TPS) ELISA Kit: MyBiosource; 2018 [User Manual for Equine Tryptase ELISA]. Available online at: https://www.mybiosource.com/horse-rtu-elisa-kits/tryptase-tps/4503084#QLAPP_MBS4503084_SC.
  28. Genorise nNori Equine IgE ELISA Kit-DataSheet: Genorise Scientific, Inc. (2019). Available online at: https://www.genorise.com/files/Nori_Equine_IgE_ELISA_Kit-DataSheet4.pdf.
  29. Marteles D, Verde MT, Conde T, Pereboom D, Casanova Á, Villanueva-Saz S, Ortín A, Fernández A. Effects of allergen-specific immunotherapy on peripheral blood regulatory T cells and serum concentrations of cytokines and immunoglobulins in horses with allergic dermatitis.. Int Immunopharmacol 2019 Sep;74:105674.
    doi: 10.1016/j.intimp.2019.105674pubmed: 31195188google scholar: lookup
  30. ZEPPA R. Role of histamine in meperidine-induced hypotension.. J Surg Res 1962 Jan;2:26-30.
    doi: 10.1016/S0022-4804(62)80027-4pubmed: 14010153google scholar: lookup
  31. Clendenen SR, Harper JV, Wharen RE Jr, Guarderas JC. Anaphylactic reaction after cisatracurium.. Anesthesiology 1997 Sep;87(3):690-2.
    doi: 10.1097/00000542-199709000-00032pubmed: 9316977google scholar: lookup
  32. Laroche D, Vergnaud MC, Sillard B, Soufarapis H, Bricard H. Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase.. Anesthesiology 1991 Dec;75(6):945-9.
    doi: 10.1097/00000542-199112000-00004pubmed: 1741515google scholar: lookup
  33. Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin.. Anesth Analg 2004 Feb;98(2):364-370.
    doi: 10.1213/01.ANE.0000097168.32472.0Dpubmed: 14742371google scholar: lookup
  34. Rook EJ, van Zanten AP, Van den Brink W, van Ree JM, Beijnen JH. Mast cell mediator tryptase levels after inhalation or intravenous administration of high doses pharmaceutically prepared heroin.. Drug Alcohol Depend 2006 Dec 1;85(3):185-90.
    doi: 10.1016/j.drugalcdep.2006.04.013pubmed: 16765536google scholar: lookup
  35. Galvão VR, Giavina-Bianchi P, Castells M. Perioperative anaphylaxis.. Curr Allergy Asthma Rep 2014 Aug;14(8):452.
    doi: 10.1007/s11882-014-0452-6pubmed: 24951238google scholar: lookup
  36. Ebo DG, Fisher MM, Hagendorens MM, Bridts CH, Stevens WJ. Anaphylaxis during anaesthesia: diagnostic approach.. Allergy 2007 May;62(5):471-87.
    doi: 10.1111/j.1398-9995.2007.01347.xpubmed: 17441788google scholar: lookup
  37. Francis A, Fatovich DM, Arendts G, Macdonald SP, Bosio E, Nagree Y, Mitenko HM, Brown SG. Serum mast cell tryptase measurements: Sensitivity and specificity for a diagnosis of anaphylaxis in emergency department patients with shock or hypoxaemia.. Emerg Med Australas 2018 Jun;30(3):366-374.
    doi: 10.1111/1742-6723.12875pubmed: 29094472google scholar: lookup
  38. Florvaag E, Johansson SG, Oman H, Venemalm L, Degerbeck F, Dybendal T, Lundberg M. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively.. Acta Anaesthesiol Scand 2005 Apr;49(4):437-44.
    doi: 10.1111/j.1399-6576.2004.00591.xpubmed: 15777289google scholar: lookup
  39. Florvaag E, Johansson SG, Oman H, Harboe T, Nopp A. Pholcodine stimulates a dramatic increase of IgE in IgE-sensitized individuals. A pilot study.. Allergy 2006 Jan;61(1):49-55.
    doi: 10.1111/j.1398-9995.2005.00933.xpubmed: 16364156google scholar: lookup
  40. Fisher MM, Baldo BA. Immunoassays in the diagnosis of anaphylaxis to neuromuscular blocking drugs: the value of morphine for the detection of IgE antibodies in allergic subjects.. Anaesth Intensive Care 2000 Apr;28(2):167-70.
    doi: 10.1177/0310057X0002800207pubmed: 10788968google scholar: lookup
  41. Wagner B. IgE in horses: occurrence in health and disease.. Vet Immunol Immunopathol 2009 Nov 15;132(1):21-30.
    doi: 10.1016/j.vetimm.2009.09.011pubmed: 19819562google scholar: lookup
  42. Muir WW. Drugs used to produce standing chemical restraint in horses.. Vet Clin North Am Large Anim Pract 1981 May;3(1):17-44.
    pubmed: 6115498doi: 10.1016/s0196-9846(17)30144-1google scholar: lookup
  43. Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management.. Drug Saf 2008;31(2):109-26.
    doi: 10.2165/00002018-200831020-00002pubmed: 18217788google scholar: lookup
  44. Götrick B, Tobin G. The xerogenic potency and mechanism of action of tramadol inhibition of salivary secretion in rats.. Arch Oral Biol 2004 Dec;49(12):969-73.
    doi: 10.1016/j.archoralbio.2004.07.007pubmed: 15485638google scholar: lookup
  45. Levy JH, Brister NW, Shearin A, Ziegler J, Hug CC Jr, Adelson DM, Walker BF. Wheal and flare responses to opioids in humans.. Anesthesiology 1989 May;70(5):756-60.
    doi: 10.1097/00000542-198905000-00008pubmed: 2470272google scholar: lookup
  46. FELDBERG W, PATON WD. Release of histamine from skin and muscle in the cat by opium alkaloids and other histamine liberators.. J Physiol 1951 Aug;114(4):490-509.
    doi: 10.1113/jphysiol.1951.sp004639pmc: PMC1392351pubmed: 14874225google scholar: lookup
  47. Auer DE, Ng JC, Reilly JS, Seawright AA. Assessment of histamine, bradykinin, prostaglandins E1 and E2 and carrageenin as vascular permeability agents in the horse.. J Vet Pharmacol Ther 1991 Mar;14(1):61-9.
    doi: 10.1111/j.1365-2885.1991.tb00805.xpubmed: 2038096google scholar: lookup
  48. ARGENT DE, DINNICK OP. Pethidine phlebitis.. Br J Anaesth 1954 Jul;26(4):260-3.
    doi: 10.1093/bja/26.4.260pubmed: 13172374google scholar: lookup
  49. LISTER RE. Pharmacological actions of two new pethidine analogues.. Br J Pharmacol Chemother 1960 Jun;15(2):254-9.
    doi: 10.1111/j.1476-5381.1960.tb01240.xpmc: PMC1481920pubmed: 14417496google scholar: lookup

Citations

This article has been cited 1 times.
  1. Yang NY, Ko JC, Wang HC, Liu PC. A preliminary study comparing the sedative, cardiorespiratory, and histaminic-releasing effects of intramuscular and intravenous administration of pethidine (meperidine) with midazolam in healthy cats.. Vet Anim Sci 2021 Dec;14:100218.
    doi: 10.1016/j.vas.2021.100218pubmed: 34825109google scholar: lookup
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.